Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0091 | 0.8 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |